MedTrace Logo

Neutrophil Function During Therapy With Protease Inhibitors in Chronic Hepatitis C

NCT02545335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 174

Last updated 2023-01-12

No results posted yet for this study

Summary

The aim of this study is to characterize neutrophil function in patients undergoing chronic hepatitis C triple therapy with protease inhibitors in comparison to dual therapy with peginterferon and ribavirin and with interferon free treatment regimen to thereby elucidate the possible mechanisms of protease-inhibitor associated infections.

Conditions

  • Chronic Hepatitis C

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Vanessa Statdlbauer, MD · Medical University of Graz

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02545335 on ClinicalTrials.gov